全球体外受精（IVF）市场规模、份额、趋势和成长分析报告（2026-2034）

体外受精（IVF）市场预计将从 2025 年的 325.8 亿美元成长到 2034 年的 552.7 亿美元，2026 年至 2034 年的复合年增长率为 6.05%。

由于不孕症上升以及人们对辅助生殖技术的认知度提高，全球体外受精（IVF）市场正经历显着成长。体外受精（IVF）是指在实验室中将卵子和精子结合，然后将胚胎移植到子宫内的过程。对于面临生育挑战的夫妻来说，这项技术已成为最广泛使用的不孕症治疗方法之一。

生殖医学和实验室技术的进步显着提高了体外受精的成功率。胚胎冷冻、基因筛检和改良的胚胎培养系统等技术正在改善治疗效果。此外，晚育、压力和环境因素等生活方式的改变也导致全球不孕症治疗需求不断增长。

随着生育诊所不断采用先进的辅助生殖技术，市场预计将会扩大。在一些地区，政府和医疗机构为生育治疗提供财政支持，有助于提高病患的就医便利性。随着医学研究的进步和人们对生育治疗方案认知度的提高，全球对体外受精服务的需求将持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球体外受精（IVF）市场：依设备分类

• 市场分析、洞察与预测
• 免洗设备
• 培养基
• 装置

第五章：全球体外受精（IVF）市场：依治疗方式划分

• 市场分析、洞察与预测
• 新鲜捐赠者
• 冷冻捐赠者
• 新鲜非捐赠者
• 冷冻非捐赠者

第六章 全球体外受精（IVF）市场：依服务提供者划分

• 市场分析、洞察与预测
• 不孕症治疗诊所
• 医院和其他设施

第七章 全球体外受精（IVF）市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Bayer AG
  • Cook Medical LLC
  • EMD Serono Inc.（Merck KGaA）
  • Ferring BV
  • FUJIFILM Irvine Scientific（FUJIFILM Holdings Corporation）
  • Genea Biomedx
  • Merck & Co. Inc
  • The Cooper Companies Inc
  • Thermo Fisher Scientific Inc
  • Vitrolife
  • Boston IVF
  • Nova IVF
  • RMA Network（Reproductive Medicine Associates）

The In Vitro Fertilization Market size is expected to reach USD 55.27 Billion in 2034 from USD 32.58 Billion (2025) growing at a CAGR of 6.05% during 2026-2034.

The global in vitro fertilization market is experiencing strong growth due to rising infertility rates and increasing awareness of assisted reproductive technologies. In vitro fertilization (IVF) involves fertilizing an egg with sperm outside the body in a laboratory before transferring the embryo into the uterus. This procedure has become one of the most widely used fertility treatments for couples experiencing reproductive challenges.

Advancements in reproductive medicine and laboratory technologies are significantly improving IVF success rates. Techniques such as embryo freezing, genetic screening, and improved embryo culture systems are enhancing treatment outcomes. Increasing lifestyle factors such as delayed parenthood, stress, and environmental influences are also contributing to the growing demand for fertility treatments worldwide.

In the future, the market is expected to expand as fertility clinics continue to adopt advanced reproductive technologies. Governments and healthcare organizations in some regions are providing financial support for fertility treatments, increasing accessibility for patients. As medical research progresses and awareness about fertility options grows, the demand for IVF services will continue to rise globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Instrument

• Disposable Devices
• Culture Media
• Equipment

By Procedure Type

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor

By Providers

• Fertility Clinics
• Hospitals & Others Setting

COMPANIES PROFILED

• Bayer AG, Cook Medical LLC, EMD Serono Inc Merck KGaA, Ferring BV, FUJIFILM Irvine Scientific FUJIFILM Holdings Corporation, Genea Biomedx, Merck Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife, Boston IVF, Nova IVF, RMA Network Reproductive Medicine Associates
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN VITRO FERTILIZATION MARKET: BY INSTRUMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Instrument
• 4.2. Disposable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Culture Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN VITRO FERTILIZATION MARKET: BY PROCEDURE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure Type
• 5.2. Fresh Donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Frozen Donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Fresh Non-donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Frozen Non-donor Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN VITRO FERTILIZATION MARKET: BY PROVIDERS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Providers
• 6.2. Fertility Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals & Others Setting Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN VITRO FERTILIZATION MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Instrument
  • 7.2.2 By Procedure Type
  • 7.2.3 By Providers
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Instrument
  • 7.3.2 By Procedure Type
  • 7.3.3 By Providers
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Instrument
  • 7.4.2 By Procedure Type
  • 7.4.3 By Providers
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Instrument
  • 7.5.2 By Procedure Type
  • 7.5.3 By Providers
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Instrument
  • 7.6.2 By Procedure Type
  • 7.6.3 By Providers
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IN VITRO FERTILIZATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bayer AG
  • 9.2.2 Cook Medical LLC
  • 9.2.3 EMD Serono Inc. (Merck KGaA)
  • 9.2.4 Ferring B.V
  • 9.2.5 FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
  • 9.2.6 Genea Biomedx
  • 9.2.7 Merck & Co. Inc
  • 9.2.8 The Cooper Companies Inc
  • 9.2.9 Thermo Fisher Scientific Inc
  • 9.2.10 Vitrolife
  • 9.2.11 Boston IVF
  • 9.2.12 Nova IVF
  • 9.2.13 RMA Network (Reproductive Medicine Associates)